Detalhe da pesquisa
1.
Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients.
Front Med (Lausanne)
; 10: 1215916, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37928473